Catherine Schulte
Stock Analyst at Baird
(3.93)
# 632
Out of 4,996 analysts
139
Total ratings
53.85%
Success rate
9.58%
Average return
Main Sectors:
Stocks Rated by Catherine Schulte
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Outperform | $141 → $142 | $123.39 | +15.08% | 17 | Aug 28, 2025 | |
| MTD Mettler-Toledo International | Maintains: Neutral | $1,210 → $1,230 | $1,204.43 | +2.12% | 10 | Aug 4, 2025 | |
| AVTR Avantor | Maintains: Outperform | $18 → $15 | $11.84 | +26.69% | 13 | Aug 4, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $553 → $567 | $464.24 | +22.14% | 28 | Jul 24, 2025 | |
| DHR Danaher | Maintains: Outperform | $226 → $229 | $184.84 | +23.89% | 11 | Jul 23, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Neutral | $3 → $2 | $2.82 | -29.08% | 6 | May 13, 2025 | |
| EXAS Exact Sciences | Maintains: Outperform | $69 → $72 | $53.57 | +34.40% | 14 | May 2, 2025 | |
| QGEN Qiagen | Maintains: Neutral | $42 → $43 | $43.90 | -2.05% | 4 | Apr 21, 2025 | |
| TECH Bio-Techne | Downgrades: Neutral | $88 → $68 | $51.84 | +31.17% | 11 | Feb 19, 2025 | |
| CSTL Castle Biosciences | Maintains: Outperform | $42 → $38 | $22.71 | +67.33% | 7 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $56 → $33 | $26.91 | +22.63% | 3 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $335 → $281 | $91.69 | +206.47% | 7 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $208 → $217 | $291.71 | -25.61% | 7 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $20 | $162.97 | -87.73% | 1 | Jun 28, 2018 |
Agilent Technologies
Aug 28, 2025
Maintains: Outperform
Price Target: $141 → $142
Current: $123.39
Upside: +15.08%
Mettler-Toledo International
Aug 4, 2025
Maintains: Neutral
Price Target: $1,210 → $1,230
Current: $1,204.43
Upside: +2.12%
Avantor
Aug 4, 2025
Maintains: Outperform
Price Target: $18 → $15
Current: $11.84
Upside: +26.69%
Thermo Fisher Scientific
Jul 24, 2025
Maintains: Outperform
Price Target: $553 → $567
Current: $464.24
Upside: +22.14%
Danaher
Jul 23, 2025
Maintains: Outperform
Price Target: $226 → $229
Current: $184.84
Upside: +23.89%
Maravai LifeSciences Holdings
May 13, 2025
Maintains: Neutral
Price Target: $3 → $2
Current: $2.82
Upside: -29.08%
Exact Sciences
May 2, 2025
Maintains: Outperform
Price Target: $69 → $72
Current: $53.57
Upside: +34.40%
Qiagen
Apr 21, 2025
Maintains: Neutral
Price Target: $42 → $43
Current: $43.90
Upside: -2.05%
Bio-Techne
Feb 19, 2025
Downgrades: Neutral
Price Target: $88 → $68
Current: $51.84
Upside: +31.17%
Castle Biosciences
Mar 1, 2023
Maintains: Outperform
Price Target: $42 → $38
Current: $22.71
Upside: +67.33%
Nov 21, 2022
Maintains: Outperform
Price Target: $56 → $33
Current: $26.91
Upside: +22.63%
Sep 22, 2020
Maintains: Neutral
Price Target: $335 → $281
Current: $91.69
Upside: +206.47%
Oct 30, 2019
Maintains: Neutral
Price Target: $208 → $217
Current: $291.71
Upside: -25.61%
Jun 28, 2018
Maintains: Outperform
Price Target: $17 → $20
Current: $162.97
Upside: -87.73%